Medtronic PLCQ1 earnings and revenue beat estimates.

Medtronic reported first-quarter earnings of $1.45 per share, surpassing the Zacks Consensus Estimate of $1.39 and up from $1.26 a year ago, marking a 4.32% surprise. Revenues reached $9.76 billion, beating estimates by 3.02% and rising from $8.58 billion in the prior year. The company has exceeded consensus EPS and revenue estimates in each of the last four quarters. Management's commentary on the earnings call will likely influence near-term stock movement, with shares down 5.6% year-to-date versus the S&P 500's 12.3% gain. The current consensus EPS estimate for the coming quarter is $1.35 on $9.47 billion in revenues, and for the full fiscal year it is $5.94 on $38.64 billion. Medtronic holds a Zacks Rank #3 (Hold), indicating expectations of in-line performance with the market.
Medtronic PLCQ1 earnings and revenue beat estimates.